Anticonvulsant hypersensitivity syndrome: Is there a role for immunomodulation?

Epilepsia

Volumn 49, Issue 12, 2008, Pages 2108-2112

  Cumbo Nacheli, Gustavo ^a,b   Weinberger, Jarrett ^b   Alkhalil, Michel ^b   Thati, Neelima ^b   Baptist, Alan P ^c  

^a Department of Internal Medicine ^*  (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anticonvulsant hypersensitivity syndrome; Drug reaction; Immunomodulation; Intravenous immunoglobulin; Liver injury; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ANTIHISTAMINIC AGENT; CORTICOSTEROID; FREE RADICAL; IMMUNOGLOBULIN; METHYLPREDNISOLONE; OXYGEN; PHENYTOIN;

ADULT; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CERVICAL LYMPHADENOPATHY; DISEASE COURSE; DRESS SYNDROME; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FLUID RESUSCITATION; HUMAN; HYDRATION; IMMUNOMODULATION; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER INJURY; MACULOPAPULAR RASH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEIZURE; SKIN BIOPSY; VITAL SIGN;

ANTICONVULSANTS; DRUG HYPERSENSITIVITY; EPILEPSY; ERYTHEMA; EXANTHEMA; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; METHYLPREDNISOLONE; MIDDLE AGED;

EID: 57449100468     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01720.x     Document Type: Article

References (38)

1. Agusti AG, Togores B, Ibanez J, Raurich JM, Maimo A, Bergada J, Marse P, Jorda R 1997) Effects of N-acetylcysteine on tissue oxygenation in patients with multiple organ failure and evidence of tissue hypoxia. Eur Respir J 10 : 1962 1966.
2. Ben-Ari Z, Vaknin H, Tur-Kaspa R 2000) N-acetylcysteine in acute hepatic failure (non-paracetamol-induced). Hepatogastroenterology 47 : 786 789.
3. Bergamini S, Rota C, Canali R, Staffieri M, Daneri F, Bini A, Giovannini F, Tomasi A, Iannone A 2001) N-acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase. Nitric Oxide 5 : 349 360.
4. Bohan KH, Mansuri TF, Wilson NM 2007) Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 27 : 1425 1439.
5. Brown CE, Smith GD, Coniglione T 1997) Anticonvulsant hypersensitivity: an unfortunate case of triple exposure to phenytoin. J Fam Pract 45 : 434 437.
6. De Swert LF, Ceuppens JL, Teuwen D, Wijndaele L, Casaer P, Casteels-Van Daele M 1984) Acute interstitial pneumonitis and carbamazepine therapy. Acta Paediatr Scand 73 : 285 288.
7. Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R 1997) N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 25 : 236 242.
8. De Vriese AS, Philippe J, Van Renterghem DM, De Cuyper CA, Hindryckx PH, Matthys EG, Louagie A 1995) Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore) 74 : 144 151.
9. Dwivedi R, Gogtay N, Kharkar V, Amladi S, Kshirsagar N 2004) In-vitro lymphocyte toxicity to a phenytoin metabolite in phenytoin induced cutaneous adverse drug eruptions. Indian J Dermatol Venereol Leprol 70 : 217 220.
10. Fervenza FC, Kanakiriya S, Kunau RT, Gibney R, Lager DJ 2000) Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment. Am J Kidney Dis 36 : 1034 1040.
11. Gressier B, Cabanis A, Lebegue S, Brunet C, Dine T, Luyckx M, Cazin M, Cazin JC 1994) Decrease of hypochlorous acid and hydroxyl radical generated by stimulated human neutrophils: comparison in vitro of some thiol-containing drugs. Methods Find Exp Clin Pharmacol 16 : 9 13.
12. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R 1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324 : 1852 1857.
13. James LP, Mayeux PR, Hinson JA 2003) Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 31 : 1499 1506.
14. Kazatchkine MD, Kaveri SV 2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345 : 747 755.
15. Kennebeck GA 2000) Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract 13 : 364 370.
16. Knowles SR, Shear NH 2007) Recognition and management of severe cutaneous drug reactions. Dermatol Clin 25 : 245 253.
17. Knowles SR, Shapiro LE, Shear NH 1999) Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 21 : 489 501.
18. Korem M, Hiller N, Ackerman Z, Chajek-Shaul T, Abramowitz Y 2006) Spleen rupture secondary to anticonvulsant hypersensitivity syndrome. Eur J Intern Med 17 : 517 519.
19. Krauss G 2006) Current understanding of delayed anticonvulsant hypersensitivity reactions. Epilepsy Curr 6 : 33 37.
20. Li AM, Nelson EA, Hon EK, Cheng FW, Chan DF, Sin NC, Ma KC, Cheung KL, Fok TF 2005) Hepatic failure in a child with anti-epileptic hypersensitivity syndrome. J Paediatr Child Health 41 : 218 220.
21. Mason ME 2007) Anticonvulsant hypersensitivity syndrome: recognizing the signs and symptoms. Resid Staff Physician 53 N, Chan B, Knowles S, Cosentino L, Shear N 2006) Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 7 : 359 368.
22. Morkunas AR, Miller MB 1997) Anticonvulsant hypersensitivity syndrome. Crit Care Clin 13 : 727 739.
23. Mostella J, Pieroni R, Jones R, Finch CK 2004) Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin. South Med J 97 : 319 321.
24. Pastor-Milán E, Rubert-Gómez MA, Vázquez- Gutiérrez F, González V 2003) Oxcarbazepine induced interstitial nephritis in a patient with drug hypersensitivity syndrome. Rev Neurol 37 : 948 950.
25. Redondo P, de Felipe I, de la Pena A, Aramendia JM, Vanaclocha V 1997) Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine. Br J Dermatol 136 : 645 646.
26. Rota C, Bergamini S, Daneri F, Tomasi A, Virgili F, Iannone A 2002) N-Acetylcysteine negatively modulates nitric oxide production in endotoxin-treated rats through inhibition of NF-κB activation. Antioxid Redox Signal 4 : 221 226.
27. Scheuerman O, Nofech-Moses Y, Rachmel A, Ashkenazi S 2001) Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin. Pediatrics 107 : E14.
28. Shear NH, Spielberg SP 1988) Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82 : 1826 1832.
29. Sheiner P, De Majo W, Levy GA 1992) Acetylcysteine and fulminant hepatic failure. Hepatology 15 : 552 554.
30. Simonart T, Tugendhaft P, Vereecken P, de Dobbeleer G, Heenen M 1998) Hazards of therapy with high doses of N-acetylcysteine for anticonvulsant- induced hypersensitivity syndrome. Br J Dermatol 138 : 553.
31. Tas S, Simonart T, Heenen M 2001) Angio-oedema caused by high doses of N-acetylcysteine in patients with anticonvulsant hypersensitivity syndrome. Br J Dermatol 145 : 856 857.
32. Ting TY 2007) Anticonvulsant hypersensitivity syndrome: identification and management. Curr Treat Options Neurol 9 : 243 248.
33. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE 1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282 : 490 493.
34. Vittorio CC, Muglia JJ 1995) Anticonvulsant hypersensitivity syndrome. Arch Intern Med 155 : 2285 2290.
35. Walsh TS, Lee A 1999) N-acetylcysteine administration in the critically ill. Intensive Care Med 25 : 432 434.
36. Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, Berry N, Stachulski AV, Clarke SE, Pichler WJ, Pirmohamed M, Park BK, Naisbitt DJ 2006) Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 118 : 233 241.
37. Zaidi AN 2005) Anticonvulsant hypersensitivity syndrome leading to reversible myocarditis. Can J Clin Pharmacol 12 : e33-e40.
38. Ziment I 1988) Acetylcysteine: a drug that is much more than a mucokinetic [review]. Biomed Pharmacother 42 : 513 519.